THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION by V. M. Paramonov, T. V. Martynyuk, N. M. Danilov, Yu. G. Matchin, I. Ye. Chazova

Get full text

THE EFFECTIVENESS OF COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN PATIENTS WITH THE CLINICAL WORSENING OF IDIOPATHIC PULMONARY HYPERTENSION ON THE BACKGROUND OF SPECIFIC MON... by V. M. Paramonov, T. V. Martynyuk, Yu. G. Matchin, V. P. Masenco, S. N. Nakonechnikov, I. Ye. Chazova

Get full text

THE EFFICACY OF SILDENAFIL THERAPY IN PATIENTS WITH PULMONARY HYPERTENSION OF DIFFERENT ETIOLOGY: INFLUENCE ON THE CLINICAL, FUNCTIONAL, HEMODYNAMIC STATUS, STRUCTURE AND FUNCTION... by T. V. Martynyuk, Z. H. Dadacheva, V. M. Paramonov, M. A. Saidova, S. N. Nakonechnikov, I. Ye. Chazova

Get full text

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION by T. V. Martynyuk, Z. H. Dadacheva, V. M. Paramonov, O. A. Arkhipova, S. N. Nakonechnikov, I. Ye. Chazova

Get full text

CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATORS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION, DEPENDING ON VASOREACTIVITY RESERVE OF PULMONARY ARTERIES by V. M. Paramonov, T. V. Martynyuk, Z. H. Dadacheva, N. M. Danilov, V. P. Masenko, I. Ye. Chazova

Get full text

CLINICAL CASE: OPPORTUNITY OF THERAPY OPTIMIZATION DUE TO TRANSITIONING FROM SILDENAFIL TO RIOCIGUAT IN PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION by I. N. Taran, V. M. Paramonov, Z. S. Valieva, M. A. Saidova, S. N. Nakonechnikov, T. V. Martynyuk, I. Ye. Chazova

Get full text

Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis by N N Yudkina, E G Valeeva, I N Taran, E V Nikolaeva, V M Paramonov, I A Kurmukov, Z S Valieva, O A Arkhipova, T V Martynyuk, A V Volkov, E L Nasonov, I E Chazova

Get full text